CMS itself has acknowledged there may be issues with whether it is adequately adjusting payments to Medicare Advantage plans to account for the costs of seriously ill patients. An Avalere analysis indicates the significance of the problem. (Avalere Report) Medicare does its risk adjustment primarily through Hierarchical Condition Categories modeling. The model has been revised, most recently in 2014, to add, delete or modify conditions. Avalere compared actual fee-for-service expenditures for beneficiaries with various chronic conditions to the costs projected by the CMS model. The researchers concluded that the model under-predicted costs for these beneficiaries by a total of 3.3% or $2.6 billion annually. On the other hand, the model appears to over-predict spending for people with no chronic conditions. In particular, the model forecast spending that was too low for rheumatoid arthritis by 15.3%, osteoarthritis by 12%, chronic kidney disease by 4% and dementia, which is not even included in the model, although it is one of the highest cost and fastest growing diseases. The model was even lower than actual spending for very high utilizers within each chronic condition. Some of the conditions with over-prediction of spending included heart attack by 11% and transplants by 15%. Some of the mismatch on under-prediction would seem to me to be driven by higher specialty drug spending for arthritis, spending that often is picked up in Part B. An interesting side fact of the analysis is that 57% of the Medicare population is said to have three or more chronic conditions. CMS has recently indicated that it will change the model and pay more with people who are dually-eligible for Medicare and Medicaid. This subset of patients tends to have more chronic conditions and higher costs. Whether these changes fully address the model inaccuracies is uncertain, but they likely erase at least some of the dissonance between model and reality. CMS has a difficult task with its Medicare Advantage rate-setting. It wants to not pay plans more than it would be paying for the same beneficiary in the fee-for-service arm of the program, but it also wants to pay plans enough to entice them to enter or stay in the program. The risk-scoring model unfortunately is the main mechanism for that balancing and appears to have some weaknesses.
Medicare Advantage Payments
By Kevin RocheFebruary 10, 2016Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 21, 2023
Minnesota’s New Energy Insanity, Part 7
Minnesota is a particularly poor place to rely on solar power, but other states aren't…
March 21, 2023
A Quick SVB Follow-up
As I suspected, the SVB saga is primarily one of regulatory malfeasance, coupled with political…
March 19, 2023
Tom Frieden Speaks in the WSJ
A public health expert writes an article for the WSJ which amply demonstrates why Americans…